Techfields   Report issue

For profit Phase 2 Phase 3
Founded: Suzhou China (2004)
Status: No NME R&D (2004)

Organization Overview

First Clinical Trial
2014
NCT02067611
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

lead institution | Techfields Inc | Techfields Pharma Co. Ltd | Tianjin XinChen-Techfields Pharma Co., LTD.